Cargando…

Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib

A 67-year-old woman with compensated cirrhosis type B associated with hepatocellular carcinoma was started on sorafenib for multiple pulmonary metastases. The patient developed right upper quadrant pain and high fever 4 weeks later. Imaging revealed marked enlargement of the gallbladder without calc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanda, Mariko, Tamai, Hideyuki, Deguchi, Hisanobu, Mori, Yoshiyuki, Moribata, Kosaku, Shingaki, Naoki, Ueda, Kazuki, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Yanaoka, Kimihiko, Oka, Masashi, Ichinose, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168393/
https://www.ncbi.nlm.nih.gov/pubmed/21991498
http://dx.doi.org/10.5402/2011/201529
_version_ 1782211381918957568
author Sanda, Mariko
Tamai, Hideyuki
Deguchi, Hisanobu
Mori, Yoshiyuki
Moribata, Kosaku
Shingaki, Naoki
Ueda, Kazuki
Inoue, Izumi
Maekita, Takao
Iguchi, Mikitaka
Yanaoka, Kimihiko
Oka, Masashi
Ichinose, Masao
author_facet Sanda, Mariko
Tamai, Hideyuki
Deguchi, Hisanobu
Mori, Yoshiyuki
Moribata, Kosaku
Shingaki, Naoki
Ueda, Kazuki
Inoue, Izumi
Maekita, Takao
Iguchi, Mikitaka
Yanaoka, Kimihiko
Oka, Masashi
Ichinose, Masao
author_sort Sanda, Mariko
collection PubMed
description A 67-year-old woman with compensated cirrhosis type B associated with hepatocellular carcinoma was started on sorafenib for multiple pulmonary metastases. The patient developed right upper quadrant pain and high fever 4 weeks later. Imaging revealed marked enlargement of the gallbladder without calculi. Following percutaneous transhepatic gallbladder aspiration, her symptoms resolved, but the gallbladder remained enlarged. Laparoscopic cholecystectomy was performed. Arteriolar occlusion with intimal thickening in the muscular layer of the gallbladder was seen sporadically. The fact that this patient had no risk factors for acalculous cholecystitis suggested that the cholecystitis resulted from ischemia, implying a strong causal relationship with sorafenib.
format Online
Article
Text
id pubmed-3168393
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-31683932011-10-11 Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib Sanda, Mariko Tamai, Hideyuki Deguchi, Hisanobu Mori, Yoshiyuki Moribata, Kosaku Shingaki, Naoki Ueda, Kazuki Inoue, Izumi Maekita, Takao Iguchi, Mikitaka Yanaoka, Kimihiko Oka, Masashi Ichinose, Masao ISRN Gastroenterol Case Report A 67-year-old woman with compensated cirrhosis type B associated with hepatocellular carcinoma was started on sorafenib for multiple pulmonary metastases. The patient developed right upper quadrant pain and high fever 4 weeks later. Imaging revealed marked enlargement of the gallbladder without calculi. Following percutaneous transhepatic gallbladder aspiration, her symptoms resolved, but the gallbladder remained enlarged. Laparoscopic cholecystectomy was performed. Arteriolar occlusion with intimal thickening in the muscular layer of the gallbladder was seen sporadically. The fact that this patient had no risk factors for acalculous cholecystitis suggested that the cholecystitis resulted from ischemia, implying a strong causal relationship with sorafenib. International Scholarly Research Network 2011 2010-11-23 /pmc/articles/PMC3168393/ /pubmed/21991498 http://dx.doi.org/10.5402/2011/201529 Text en Copyright © 2011 Mariko Sanda et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sanda, Mariko
Tamai, Hideyuki
Deguchi, Hisanobu
Mori, Yoshiyuki
Moribata, Kosaku
Shingaki, Naoki
Ueda, Kazuki
Inoue, Izumi
Maekita, Takao
Iguchi, Mikitaka
Yanaoka, Kimihiko
Oka, Masashi
Ichinose, Masao
Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
title Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
title_full Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
title_fullStr Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
title_full_unstemmed Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
title_short Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
title_sort acalculous cholecystitis in a patient with hepatocellular carcinoma on sorafenib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168393/
https://www.ncbi.nlm.nih.gov/pubmed/21991498
http://dx.doi.org/10.5402/2011/201529
work_keys_str_mv AT sandamariko acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT tamaihideyuki acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT deguchihisanobu acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT moriyoshiyuki acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT moribatakosaku acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT shingakinaoki acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT uedakazuki acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT inoueizumi acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT maekitatakao acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT iguchimikitaka acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT yanaokakimihiko acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT okamasashi acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib
AT ichinosemasao acalculouscholecystitisinapatientwithhepatocellularcarcinomaonsorafenib